Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells

Epigenetic silencing is considered to be a major mechanism for loss of activity in tumor suppressors. Reversal of epigenetic silencing by using inhibitors of DNA methyltransferase (DNMT) or histone deacetylases (HDACs) such as 5-Aza-CdR and FK228 has shown to enhance cytotoxic activities of several...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jong Kook, Seo, Jung Seon, Lee, Suk Kyeong, Chan, Kenneth K, Kuh, Hyo-Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254647/
https://www.ncbi.nlm.nih.gov/pubmed/30173503
http://dx.doi.org/10.4062/biomolther.2018.061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254647/
https://www.ncbi.nlm.nih.gov/pubmed/30173503
http://dx.doi.org/10.4062/biomolther.2018.061

Ejemplares similares